These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 31258627)

  • 1. Next-generation sequencing and biomarkers for gastric cancer: what is the future?
    Kawazoe A; Shitara K
    Ther Adv Med Oncol; 2019; 11():1758835919848189. PubMed ID: 31258627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dawn of precision medicine on gastric cancer.
    Ishii T; Kawazoe A; Shitara K
    Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drug developments in metastatic gastric cancer.
    Tan AC; Chan DL; Faisal W; Pavlakis N
    Therap Adv Gastroenterol; 2018; 11():1756284818808072. PubMed ID: 30455742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives.
    Niclauss N; Gütgemann I; Dohmen J; Kalff JC; Lingohr P
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Targeted Therapies in Management of Metastatic Urothelial Cancer in the Era of Immunotherapy.
    Grivas P; Yu EY
    Curr Treat Options Oncol; 2019 Jun; 20(8):67. PubMed ID: 31254108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Systemic Therapy for Metastatic or Advanced Gastric Cancer.
    Shitara K; Ohtsu A
    J Natl Compr Canc Netw; 2016 Oct; 14(10):1313-1320. PubMed ID: 27697983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Therapies in Advanced Gastric Cancer.
    Patel TH; Cecchini M
    Curr Treat Options Oncol; 2020 Jul; 21(9):70. PubMed ID: 32725377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive biomarkers in gastric cancer.
    Röcken C
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):467-481. PubMed ID: 36260159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Top advances of the year: Precision oncology.
    Desai A; Reddy NK; Subbiah V
    Cancer; 2023 Jun; 129(11):1634-1642. PubMed ID: 36946766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-Art Advancements in Gastroesophageal Cancer Treatment: Harnessing Biomarkers for Precision Care.
    Balmaceda NB; Petrillo A; Krishnan M; Zhao JJ; Kim S; Klute KA; Sundar R
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e431060. PubMed ID: 38771996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current advances in targeted therapy for metastatic colorectal cancer - Clinical translation and future directions.
    Johnson D; Chee CE; Wong W; Lam RCT; Tan IBH; Ma BBY
    Cancer Treat Rev; 2024 Apr; 125():102700. PubMed ID: 38422896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer.
    Zhang Z; Xie T; Wang Y; Shen L; Zhang X; Peng Z
    Ther Adv Med Oncol; 2024; 16():17588359241231253. PubMed ID: 38362378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of immune checkpoint inhibitors in immunotherapy for gastric cancer.
    Wu YX; Zhou XY; Wang JQ; Chen GM; Chen JX; Wang RC; Huang JQ; Chen JS
    Immunotherapy; 2023 Feb; 15(2):101-115. PubMed ID: 36597704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular Subtypes of Gastric Cancer].
    Hatogai K; Doi T
    Gan To Kagaku Ryoho; 2016 Mar; 43(3):281-5. PubMed ID: 27067842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine in gastric cancer: Where are we and where are we going?
    Jácome AA; Coutinho AK; Lima EM; Andrade AC; Dos Santos JS
    World J Gastroenterol; 2016 Jan; 22(3):1160-71. PubMed ID: 26811654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic pathobiology of gastric carcinoma.
    Katoh H; Ishikawa S
    Pathol Int; 2017 Feb; 67(2):63-71. PubMed ID: 28004449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and prospects of biomarker-based targeted therapy and immune checkpoint inhibitors in advanced gastric cancer.
    Zeng Z; Zhu Q
    Front Oncol; 2024; 14():1382183. PubMed ID: 38947886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
    Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
    World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.